Most colon cancers are thought to develop through thè adenoma-to-carcinoma sequence' model. To elucidate the mechanisms underlying this pathway, we analysed gene-expression pro®les of 20 colorectal tumors (nine adenomas and 11 dierentiated adenocarcinomas) by means of a cDNA microarray representing 23 040 genes coupled with laser-capture microdissection. A twodimensional hierarchical clustering analysis of expression pro®les of the 20 tumors correctly separated the carcinoma group from the adenoma group. Furthermore we identi®ed 51 genes whose expression was commonly up-regulated, 376 that were commonly down-regulated in both types of tumors as opposed to normal colonic epithelium and 50 whose expression levels were signi®cantly dierent between adenomas and carcinomas. On the basis of expression pro®les of the 50 discriminating genes, we established a scoring system to separate adenomas from carcinomas. Application of this scoring system for evaluating ®ve additional colorectal tumors correctly predicted their histological features. The genome-wide information reported here should contribute to a more profound understanding of colorectal tumorigenesis, particularly of adenoma-carcinoma progression, and provide indicators for developing novel strategies to diagnose, treat, and ultimately prevent colorectal carcinomas.
Introduction
Colorectal carcinoma is a leading cause of cancer deaths in developed countries. Recent medical advances have made great progress in diagnosis and treatment, but many patients with advanced colorectal cancers still wait for more eective but less harmful therapeutic drugs. Development of a sensitive, speci®c and convenient diagnostic system for detecting very early-stage colorectal cancers or pre-malignant lesions could ultimately eliminate this disease. Furthermore, identi®cation of eective preventive strategies would release people from fear of this life-threatening illness. Muto et al. (1975) ®rst described pre-malignant lesions of the colon on the basis of careful histological examination and proposed a model of`adenomacarcinoma sequence of the colon'. Subsequent molecular studies during the past two decades have opened the door to a better understanding of colorectal carcinogenesis and established a view of multi-step carcinogenesis in the colon that agrees well with Muto's. Investigations of hereditary colon cancers have improved the general understanding of mechanisms underlying sporadic colorectal carcinomas. However, our knowledge of genes involved in colorectal tumors is still fragmentary and awaits genome-wide information about how expression pro®les are altered during multi-step carcinogenesis.
Analysis of expression pro®les using cDNA microarrays is a promising method for identifying genes whose expression is altered by response to various physiological conditions or drugs, or pathological conditions (Afshari et al., 1999; Kallioniemi, 2001 ). This technology can also provide systematic expression pro®les that may re¯ect the physiological or pathological phenotype of a subset of a cell population. This approach has proven to be useful for analysing genes involved in various neoplasms and for detecting speci®c phenotypes (Ono et al., 2000; Okabe et al., 2001; Kitahara et al., 2001) . We were interested in examining expression pro®les of pre-malignant and malignant lesions of the colon, because comparison of these two groups of tumors would provide information about genes that undergo altered expression during progression of an adenoma to a carcinoma.
We report here a genome-wide analysis of geneexpression pro®les in nine pre-malignant lesions and 11 dierentiated adenocarcinomas of the colon by means of a cDNA microarray representing 23 040 genes. We identi®ed a panel of genes that were commonly deregulated in both colorectal adenomas and carcinomas, and also 50 genes whose expression diered signi®cantly between benign and malignant tumors. We established a scoring system on the basis of expression of selected genes that may assist clinicians in distinguishing adenomas from carcinomas. The data reported here will add to a comprehensive understanding of colorectal carcinogenesis, facilitate development of novel diagnostic strategies, and provide clues for identi®cation of molecular targets for therapeutic drugs and preventive agents.
Results

Two-dimensional hierarchical clustering
To analyse correlation among the samples and genes, we applied a two-dimensional hierarchical clustering algorithm (http://www.microarrays.org/software) using the data obtained from the 20 tumors. We excluded genes for further analysis when average Cy3-and Cy5-uorescence intensities were below 1610 5 units, and selected a set of genes whose values were obtained in more than 16 cases (80%). We further excluded genes with standard deviations of observed values less than 0.5. A total of 771 genes passed this ®lter for subsequent clustering analysis.
In the sample axis, the 20 samples were separated into two major groups based on their expression pro®les; all of the nine tumors belonging to one group were adenomas and the other major group consisted of the 11 carcinomas (Figure 1 ). This result is consistent with a recent report that four colon adenomas were separated from 18 adenocarcinomas using oligonucleotide arrays (Notterman et al., 2001) . The expression pro®les obtained on our microarray clearly demonstrated that adenomas and adenocarcinomas have speci®c expression pro®les, and indicated that molecular classi®cation of colonic tumors is feasible. Our data also disclosed the molecular nature of each tumor type. In the gene axis, we later focused on two gene clusters, cluster A (more abundant expression in carcinomas than adenomas) and cluster B (more abundant expression in adenomas than carcinomas).
Genes commonly up-regulated in colonic tumors
Since most colon cancers arise from adenomas, genes involved in early stages of colorectal tumorigenesis are likely to be deregulated in both types of tumors. To identify such genes, we selected genes from our data set of 2425 genes according to the following criteria: if the Cy3/Cy5 ratio of the gene was 42 in more than 50% of the tumors, we de®ned it as a commonly upregulated gene, and if the ratio was 50.5 in more than 50% of the tumors, we de®ned it as commonly downregulated. With these criteria we identi®ed 51 genes that were commonly up-regulated in both tumor phenotypes as compared with their corresponding normal epithelia (Figure 2) . Among the 51 genes, 19 were involved in RNA/protein processing; e.g. ribosomes, translation elongation/initiation factors, and chaperonins. Other up-regulated genes detected in our experiments included oncogenes (HMGIY, DEK and NPM1), genes encoding cell adhesion/cytoskeleton molecules (TUBB, K-ALPHA, TGFBI, CDH3 and PAP), genes involved in growth control (IMPDH2 and ODC1), signal transduction (BRF1, PLAB, LAP18, CD81 and MACMARCKS), and cell-cycle control (RAN and UBE2I); transcription factors ; more intense colors re¯ect wider dierences between tumor and normal epithelium. Red, increased in tumor; green, decreased; black, unchanged; gray, no expression in the tumor cells. In the sample axis, carcinomas (T) and adenomas (P) were separated to two dierent trunks. In the gene axis, 771 genes were clustered in dierent branches according to their similarity; the shorter the branches the greater the similarity. Sub-clusters A and B were selected for further analysis (see text and Figure 3) (HMG1 and HMG2), tumor-associated molecules (PPP2R1B, LDHB and SLC29A1), and others.
Genes commonly down-regulated in colonic tumors
We also identi®ed 376 genes (including 127 expressed sequence tags) that were commonly down-regulated in both types of tumor by the criteria described above (supplementary data). This group includes genes associated with programmed cell death (CASP8, CASP9, CFLAR, DFFA, PAWR, TNF, TNFRSF10C and TNFRSF12), immunity (chemokine receptors such as IL1RL2, IL17R and IL3RA), growth suppression (Suppressin, DCN, MADH2 and SST), and tumor suppression (TP53). Other down-regulated genes encode cell adhesion/cytoskeleton molecules (e.g. ADAM8, AVIL, CDH17, CEACAM1, CTNNA2, ICAPA, KRT9, and ARHGAP5), various metabolic factors (e.g. BPHL, CA2, CA5A, HSD11B2 and ECHS1), ion transporters (SLC15A2, SLC22A1, SLC4A3 and SLC5A1), a natural antimicrobial molecule (DEFA6), and others. Metabolic enzymes and ion-transport mediators are key factors for maintaining pivotal cellular functions such as detoxication (CA2, CA5A and BPHL) and acid-base balance. Down-regulation of these genes indicates a disruption of cellular homeostasis in tumors (Lawrance et al., 2001) .
Genes expressed differently between adenomas and carcinomas
When we focused on genes in clusters A and B (Figure 3 ), we identi®ed several that regulate bioenergetics. In cluster A, PGK1 and LDHA may be induced by hypoxia (Semenza et al., 1994) . Proteasomes (PSMD7 and PSMB8) have been reported to accumulate in cancer cells by glucose starvation and hypoxia (Ogiso et al., 1999) . VDAC3 is one of the voltage-dependent anion-selective channel proteins that play important roles in regulating mitochondrial homeostasis (Vander Heiden et al., 2000) . GSS is a regulator of oxidative stress (Uhlig and Wendel, 1992) . Some of the genes in cluster B encode proteins that have been reported to function in adaptation to low-oxygen conditions (GPX2, PPIA, GAPD, ANXA2, ALDH1 and ADAR) (Chu et al., 1993; Zhong and Simons, 1999; Hoeren et al., 1998; Denko et al., 2000) , in energy consumption (ATP6A1, ATP1B1, and ATP5A1) (Wodopia et al., 2000) or in carbohydrate metabolism (GMDS). 
Verification of microarray data by quantitative-RT ± PCR
To examine the reliability of our microarray data, we selected six genes, two of which (TGFBI and LAP18) were up-regulated in both adenomas and carcinomas and the others (HECH, NME1, TCEA1 and PSMA7) were dierently expressed between adenomas and carcinomas, and examined their expression in 13 additional paired aRNA samples (seven adenomas and six carcinomas) by quantitative RT ± PCR (QRT ± PCR). The results were highly similar to microarray data for all six genes (Figure 4 ). These data veri®ed the reliability and rationality of our strategy to identify genes that are commonly upregulated or dierently expressed during development and progression of colorectal cancer.
Comparison of expression analysis data in colon cancers
We additionally compared our data with two sets of data reported previously. Information of gene expression pro®les in two colon cancer tissues and two noncancerous colonic mucosae analysed by means of Serial Analysis of Gene Expression was provided by National Center for Biotechnology Information (http:// www.ncbi.nlm.nih.gov/SAGE/). Among 100 tags of genes expressed most dierently between the cancer and non-cancerous tissues, 50 tags corresponded to independent unique genes in UniGene database. Among 50 genes corresponding to these 50 tags, four up-regulated genes and 24 down-regulated genes in cancer were contained in our microarray. One of the four up-regulated gene, TGFBI (transforming growth factor, beta-induced, 68 kD) also showed elevated expression in our data (Figure 2) . Eighteen of the 24 down-regulated genes including TSPAN-1 (tetraspan1), GPA33 (glycoprotein A33), CA1 (carbonic anhydrase 1), MT2A (metallothionein 2A), CEACAM1 (carcinoembryonic antigen-related cell adhesion molecule 1), YF13H12 (protein expressed in thyroid), MUC13 (mucin 13), HLAB (major histocompatibility complex class 1B), DUSP1 (dual speci®city phosphatase 1), GSN (gelsolin), LGALS4 (galectin 4), CKB (creatinine . Genes that appear repeatedly represent the same genes spotted on dierent set of slides kinase, brain type), KRT19 (keratin 19), RNASE1 (RNase A family 1), IFI27 (interferon, alpha-inducible protein 27), PP1201, EPS8R2 (FLJ21935), and an EST(Hs. 107139) revealed decreased expression in more than half the cases examined by us. We also compared a list of genes highly expressed in colon cancer tissues compared to the matched non-cancerous tissues, which was reported by Notterman et al. (2001) using the Aymetrix Human 6500 GeneChip Set, and found that only two genes, GTF3A (general transcription factor IIIA) and AHCY (adenosylhomocysteine hydrolase), were in our list of frequently up-regulated genes in cancer ( Figure 5A ). However, among 10 other genes that were highly expressed in their cancer tissues and spotted on our array slides, eight genes, such as KIAA0101, PYCR1 (pyrroline 5-carboxylate reductase), HSPE1 (heat shock 10 kD protein 1), CDC25B (cell division cycle 25B), CSE1L (chromosome segregation 1-like), CKS2 (CDC28 protein kinase 2), MMP1 (metalloprotenase 1), and CLNS1A (chloride channel, nucleotide-sensitive, 1A), also showed enhanced expression in more than half of cancer tissues.
Development of a`Molecular Diagnosis Score' (MDS) system
Among the genes expressed dierently between adenomas and carcinomas, we identi®ed 50 whose expression showed statistically signi®cant dierences between the two types of tumors (P40.01, Mann ± Whitney U-test; Figure 5A ). We developed a`Molecular Diagnosis Score' (MDS) system based on expression pro®les of these 50 genes (see Materials and methods) as a way to apply that information to clinical diagnosis. The mean score of the 11 carcinomas was 77.4+11.6, while that of the nine adenomas was 75.9+14.4 (mean+s.d., P50.0001, Mann ± Whitney U-test; Figure 5B ). We de®ned the cut-o value for discriminating adenocarcinoma from adenoma at 35, an average of the mean values of the two groups, and analysed ®ve additional tumors to verify the reliability of the MDS system. Among the ®ve samples tested, three that showed scores greater than 35 (73.5, 63.2, and 64.6) all turned out to be carcinomas by histological examination. The two samples with scores of 10.3 and 71.4 were both adenomas ( Figure 5B ). Since the distribution of MDSs for 14 carcinomas ranging from 57.7 to 94.1 were completely separated from that for 11 adenomas ranging from 733.4 to 16.7, both sensitivity and speci®city of the MDS system were 100% on the basis of this cut-o value. In addition, a hierarchical clustering analysis of all 25 samples correctly separated adenomas from carcinomas based on the expression pro®les of the 50 selected genes ( Figure 5A ).
Discussion
In this study, we disclosed common nature of adenoma and adenocarcinoma of the colon through the analysis of genome-wide expression pro®les. The 51 genes commonly up-regulated in both adenomas and carcinomas included 19 involved in RNA/protein processing; e.g. ribosomes, translation elongation/initiation factors, and chaperonins. Ribosomes are the molecular machines that manufacture proteins according to blueprints of mRNAs that encode them. Interactions of the ribosome with mRNAs, tRNAs, and a number of non-ribosomal protein cofactors such as translation initiation/elongation factors guarantee that polypeptide chains are The data for each gene were ®rst median-centered, and an`Average Linkage Clustering' was subsequently applied to the data set (red, data 4median value; green, data 5median value). In the sample axis, 25 tumors were separated to two trunks (adenoma group and carcinoma group). Asterisks (*) indicate additional test samples. A sample, 056P3, was diagnosed as an early adenocarcinoma by histological examination. In the gene axis, the 18 genes on the top showed higher expression in carcinoma than in adenoma, and were labeled with`1' as a sign. The 32 genes at the bottom showed higher expression in adenoma than in carcinoma, and were labeled with`71' as a sign (see Materials and methods). Statistical signi®cance was examined by the Mann ± Whitney U-test. (B) MDSs were presented as 10 ± 90th percentiles of the calculated values. Asterisks denote the ®ve additional samples for validating the MDS system. Tumor 056P3 is a well-dierentiated adenocarcinoma initiated, elongated and terminated (Maguire and Zimmerman, 2001) . After translation, polypeptides emerge from the ribosomes and enter the endoplasmic reticulum where chaperonins may remodel the polypeptides (Boon et al., 2001) . Therefore accelerated protein synthesis appears to be a common feature of adenomas and carcinomas and re¯ects a heavy proliferative burden in both tumor types. In addition, our data suggest that activation of oncogenes, aberrant transduction of signals, deregulation of the cell cycle, impaired growth control, and remodeling of cytoskeletal structures are general features of tumor cells (Hanahan and Weinberg, 2000) . Targeting these genes or the molecules they encode could be an important strategy for developing novel approaches to prevention, diagnosis, and treatment of colorectal cancer.
The commonly down-regulated genes included a number of genes associated with cell death, which may imply that broad repression of programed celldeath pathways is a crucial step for colorectal tumorigenesis. In addition, the list of commonly down-regulated genes suggests that reduction of growth-suppressive signals and/or tumor-suppressive functions may confer continuous proliferative properties to neoplastic cells. Therefore, induction of genes categorized in this cluster may be a potential approach for development of novel cancer therapies.
We also revealed that a number of genes discriminating carcinoma from adenoma were relevant to hypoxia. Conceivably, carcinoma cells may be more exposed to starved and hypoxic conditions, where carbohydrate/oxygen homeostasis is impaired, than are adenoma cells. Therefore our data may imply that cancer cells are changing their expression pro®les in response to low-nutrient and hypoxic conditions. Since hypoxia is a prognostic indicator in a number of tumors (Denko et al., 2000) , targeting the genes in this category may help us to clarify micro-environmental changes during malignant transformation, and to identify novel prognostic predictors for colon cancer.
Consideration of the nature of the genes described above leads us to conclude that activation of oncogenes, augmentation of proliferation signals, attenuation of anti-proliferative signals, avoidance of self-destruction machinery, alteration of cell structure, and adaptation to micro-environmental changes, are of great importance for the development and progression of normal colonic mucosal cells to adenocarcinomas. These six features suggest that adenoma and carcinoma cells share several genetic characteristics but have unique expression pro®les, and this information may guide eorts to identify novel targets for blocking malignant transformation.
The results of MDS system using expression pro®les of the 50 genes corroborated its feasibility for predicting the histological features of colorectal tumors. Analysis of gene-expression pro®les of very early colon cancers will be necessary for de®ning a more precise cut-o value to distinguish between benign and malignant lesions; moreover, the scoring system must be validated using bulk tumors before it can become a tool for clinical diagnosis. Nevertheless, since histological diagnosis of adenomas and carcinomas is sometimes very dicult and may vary among pathologists (Schlemper et al., 2000) , the MDS system may ultimately be useful in distinguishing benign from malignant tumors because it is an objective quanti®cation of each tumor on the basis of a genome-wide database.
In conclusion, the gene-expression analysis of colorectal adenomas and carcinomas reported here, obtained through a combination of laser-capture dissection and a genome-wide cDNA microarray, provides a large body of information to clarify the mechanisms of colorectal tumorigenesis and should contribute to identi®cation of molecular targets for prevention, diagnosis and treatment of colorectal tumors. Moreover, the novel MDS system that we developed, based on a subset of 50 genes, may facilitate more sensitive, speci®c and precise diagnosis of such tumors.
Materials and methods
Tissue samples and laser-capture microdissection (LCM)
Eleven dierentiated adenocarcinomas, nine adenomas, and their corresponding normal mucosae of the colon were obtained with informed consent from 16 patients who underwent colectomy. In four cases, both adenomas and carcinomas had arisen in the same patient. All 20-paired samples were embedded in TissueTek OCT medium (Miles, Inc.) and frozen at 7808C. Procedures of ®xation, staining and LCM were performed as described previously . About 10 000 cells were selectively collected by LCM from each tissue sample.
RNA extraction, T7-based RNA amplification and cDNA microarray Extraction of total RNA and T7-based RNA ampli®cation were carried out as described previously . Two rounds of ampli®cation yielded 15 ± 80 mg of ampli®ed RNA (aRNA) from each sample. A 2.5 mg aliquot of aRNA from each tumor and normal epithelium were labeled with Cy3-dCTP and Cy5-dCTP respectively (Amersham Pharmacia Biotech). To reduce experimental¯uctua-tion, we used duplicate sets of cDNA microarray slides containing 23 040 cDNAs for each analysis. Fabrication of the cDNA microarray slides, hybridization, washing, and detection of signals were carried out as described elsewhere (Ono et al., 2000) . The 23 040 genes were selected from UniGene database (National Center for Biotechnology Information) and their cDNA fragments were ampli®ed by RT ± PCR using gene-speci®c primers for each gene and a variety of human poly(A) + RNAs as template (Clontech).
Data analysis
The intensity of each signal of Cy3 and Cy5 was evaluated photometrically using ArrayVision software (Imaging Research Inc., St. Catharines, Ont. Canada) and normalized according to the expression of 52 housekeeping genes . After normalization, each gene was separated into one of four categories based on the average Cy3/Cy5 ratio (r): up-regulated (r42), down-regulated (r50.5), unchanged (0.55r52) and low (expression level below cuto level for detection). Excel, Cluster and TreeView software packages were used for subsequent analysis.
Validation of data
To assess the reproducibility of hierarchical clustering, we compared clustering results in the sample axis by using dierent sets of genes (23 040 target sequences were spotted on ®ve slides, and we performed clustering analysis for the 20 samples in all ®ve sets). When one sample consistently fell into the same cluster in dierent sets of genes, we de®ned the data as reproducible. The reproducibility was more than 80% when Cy3 or Cy5¯uorescent units were above 100 000. Therefore, we ®rst calculated average Cy3-and Cy5-uorescence intensities of each gene in all 20 cases, excluded genes for further analysis when both intensities were below 1610 5 units, and selected a total of 2425 genes. A great majority of their spots (more than 99% of spots) had S/N ratios greater than 3.0. We further chose 771 genes whose values were obtained in more than 16 cases (80%) and their standard deviations of observed values were grater than 0.5.
Calculation of`Molecular Diagnosis Score' (MDS)
The MDS of each tumor was de®ned as the sum of weighted log ratios of expression pro®les of the 50 genes selected as dierentially expressed in adenomas vs carcinomas: MDS i =SS k log 2 (r ik ), where r ik is the expression ratio (Cy3/ Cy5) of gene k of patient i, and S k is the sign for gene k which was determined as follows: we ®rst calculated the average log ratio log 2 (r ik ) for gene k in the 11 adenocarcinomas and the nine adenomas (ave carcinoma =Slog 2 (r ik )/ n carcinoma and ave adenoma =Slog 2 (r ik )/n adenoma ). Then, we determined the sign for each gene: S k =+1, if ave carcinoma 4 ave adenoma , and S k =71, if ave carcinoma 5 ave adenoma ( Figure 4A ).
Real-time quantitative RT ± PCR
To verify our microarray data, we selected six genes and examined their expression levels in 13 additional samples (seven adenomas and six carcinomas) by means of real-time quantitative RT ± PCR (TaqMan PCR, Perkin-Elmer) (Heid et al., 1996) , using a 7700 Sequence Detector (Perkin-Elmer). Each single-stranded cDNA was reverse-transcribed from ampli®ed RNA and diluted for subsequent PCR ampli®ca-tion. Malate dehydrogenase 1 (MDH1) served as a relative quantitative control since it showed the smallest Cy3/Cy5 uctuations in 100 hybridizations. Each PCR was carried out in a 25-ml volume and ampli®ed for 10 min at 958C for activation of AmpliTaq Gold TM , followed by 40 cycles of 958C for 15 s and 608C for 1 min. The genes and sequences of the primers and probes used for quantitative RT ± PCR are listed in Table 1 .
Statistics
Assessment of statistical dierences of gene expression in carcinomas vs adenomas was determined by Mann ± Whitney U-tests. A P value 40.05 was considered statistically signi®cant. Statistical analyses were performed using Stat View software.
